Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - REARDON WILLIAM S
Last Updated 
3-Jul-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

REARDON WILLIAM S: Declared Holdings
Company/RelationshipReportedShares  Ownership
H&Q Healthcare Investors Common
Director
NYSE:HQH
(historical quotes, other insiders)
24-Jun-141,470  Direct
H&Q Life Sciences Investors Com
Director
NYSE:HQL
(historical quotes, other insiders)
30-Jun-141,612  Direct
Idera Pharmaceuticals, Inc.
Director
NasdaqCM:IDRA
(historical quotes, profile, other insiders)
1-Jul-1421,157  Direct
Synta Pharmaceuticals Corp.
Director
NasdaqGM:SNTA
(historical quotes, profile, other insiders)
1-Jul-1441,439  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Jul-14 2,363IDRA Acquisition (Non Open Market) at $2.83 per share.
(Value of $6,687)
1-Jul-14 4,878SNTA Acquisition (Non Open Market) at $0 per share.
30-Jun-14 200HQL Purchase at $19.75 per share.
(Cost of $3,950)
24-Jun-14 742HQH Option Exercise at $25.04 per share.
(Cost of $18,579)
24-Jun-14 578HQL Option Exercise at $19.75 per share.
(Cost of $11,415)
13-Nov-13 13,333SNTA Purchase at $3.75 per share.
(Cost of $49,998)
16-Sep-13 13,561IDRA Purchase at $1.82 per share.
(Cost of $24,681)
1-Jul-13 4,000SNTA Acquisition (Non Open Market) at $0 per share.

 

 


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?